BRPI0923903A2 - Derivados de piridazinona - Google Patents
Derivados de piridazinonaInfo
- Publication number
- BRPI0923903A2 BRPI0923903A2 BRPI0923903-0A BRPI0923903A BRPI0923903A2 BR PI0923903 A2 BRPI0923903 A2 BR PI0923903A2 BR PI0923903 A BRPI0923903 A BR PI0923903A BR PI0923903 A2 BRPI0923903 A2 BR PI0923903A2
- Authority
- BR
- Brazil
- Prior art keywords
- pyridazinone derivatives
- pyridazinone
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102009004061A DE102009004061A1 (de) | 2009-01-08 | 2009-01-08 | Pyridazinonderivate |
DE102009004061.7 | 2009-01-08 | ||
PCT/EP2009/008839 WO2010078909A1 (de) | 2009-01-08 | 2009-12-10 | Pyridazinonderivate |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0923903A2 true BRPI0923903A2 (pt) | 2015-07-28 |
BRPI0923903B1 BRPI0923903B1 (pt) | 2020-03-24 |
BRPI0923903B8 BRPI0923903B8 (pt) | 2021-05-25 |
Family
ID=41581157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0923903A BRPI0923903B8 (pt) | 2009-01-08 | 2009-12-10 | derivados de piridazinona, e medicamentos. |
Country Status (24)
Country | Link |
---|---|
US (1) | US8623870B2 (pt) |
EP (1) | EP2373647B1 (pt) |
JP (1) | JP5683488B2 (pt) |
KR (1) | KR101669696B1 (pt) |
CN (1) | CN102272131A (pt) |
AR (1) | AR074997A1 (pt) |
AU (1) | AU2009336851B2 (pt) |
BR (1) | BRPI0923903B8 (pt) |
CA (1) | CA2749015C (pt) |
CY (1) | CY1113700T1 (pt) |
DE (1) | DE102009004061A1 (pt) |
DK (1) | DK2373647T3 (pt) |
EA (1) | EA020574B1 (pt) |
ES (1) | ES2398023T3 (pt) |
HR (1) | HRP20120976T1 (pt) |
IL (1) | IL213826A (pt) |
MX (1) | MX2011007209A (pt) |
PL (1) | PL2373647T3 (pt) |
PT (1) | PT2373647E (pt) |
SG (1) | SG172458A1 (pt) |
SI (1) | SI2373647T1 (pt) |
SM (1) | SMT201300010B (pt) |
WO (1) | WO2010078909A1 (pt) |
ZA (1) | ZA201105781B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11034669B2 (en) | 2018-11-30 | 2021-06-15 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5795964A (en) | 1980-12-04 | 1982-06-15 | Morishita Seiyaku Kk | Preparation of 2-substituted-3(2h)-pyridazinone derivative |
US4397854A (en) | 1981-05-14 | 1983-08-09 | Warner-Lambert Company | Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents |
IL115889A0 (en) | 1994-11-14 | 1996-01-31 | Rohm & Haas | Pyridazinones and their use as fungicides |
US5635494A (en) | 1995-04-21 | 1997-06-03 | Rohm And Haas Company | Dihydropyridazinones and pyridazinones and their use as fungicides and insecticides |
GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
HUP9901155A3 (en) | 1996-02-13 | 2003-04-28 | Astrazeneca Ab | Quinazoline derivatives as vegf inhibitors |
KR100489174B1 (ko) | 1996-03-05 | 2005-09-30 | 제네카-파마 소시에떼아노님 | 4-아닐리노퀴나졸린유도체 |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
CN1142148C (zh) | 1997-11-19 | 2004-03-17 | 兴和株式会社 | 新颖的哒嗪衍生物和含有其作为有效成分的药物 |
TWI241295B (en) | 1998-03-02 | 2005-10-11 | Kowa Co | Pyridazine derivative and medicine containing the same as effect component |
GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
KR20030013433A (ko) | 2000-05-31 | 2003-02-14 | 아스트라제네카 아베 | 혈관 손상 활성을 가진 인돌 유도체 |
HUP0301742A3 (en) | 2000-07-07 | 2005-08-29 | Angiogene Pharm Ltd | Colchinol derivatives as angiogenesis inhibitors, process for producing them, pharmaceutical compositions containing them and their use |
EP1301497A1 (en) | 2000-07-07 | 2003-04-16 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as vascular damaging agents |
US20040259863A1 (en) | 2001-10-31 | 2004-12-23 | Hans-Michael Eggenweiler | Type 4 phosphodiesterase inhibitors and uses thereof |
US6825170B2 (en) | 2001-12-05 | 2004-11-30 | Ortho-Mcneil Pharmaceutical, Inc. | 6-O-acyl ketolide antibacterials |
WO2005121132A1 (ja) | 2004-06-11 | 2005-12-22 | Shionogi & Co., Ltd. | 抗hcv作用を有する縮合ヘテロ環化合物 |
DE102005057924A1 (de) * | 2005-12-05 | 2007-06-06 | Merck Patent Gmbh | Pyridazinonderivate |
DK1959955T3 (da) | 2005-12-05 | 2011-02-07 | Pfizer Prod Inc | Fremgangsmåde til behandling af abnorm cellevækst |
DE102006037478A1 (de) * | 2006-08-10 | 2008-02-14 | Merck Patent Gmbh | 2-(Heterocyclylbenzyl)-pyridazinonderivate |
TW200845991A (en) * | 2007-01-12 | 2008-12-01 | Smithkline Beecham Corp | N-substituted glycine derivatives: hydroxylase inhibitors |
DE102007061963A1 (de) * | 2007-12-21 | 2009-06-25 | Merck Patent Gmbh | Pyridazinonderivate |
US20110245209A1 (en) * | 2008-12-16 | 2011-10-06 | Schering Corporation | Pyridopyrimidine derivatives and methods of use thereof |
DE102009003954A1 (de) * | 2009-01-07 | 2010-07-08 | Merck Patent Gmbh | Pyridazinonderivate |
-
2009
- 2009-01-08 DE DE102009004061A patent/DE102009004061A1/de not_active Withdrawn
- 2009-12-10 DK DK09768339.5T patent/DK2373647T3/da active
- 2009-12-10 US US13/143,646 patent/US8623870B2/en active Active
- 2009-12-10 EA EA201101038A patent/EA020574B1/ru not_active IP Right Cessation
- 2009-12-10 CN CN2009801537887A patent/CN102272131A/zh active Pending
- 2009-12-10 SG SG2011048568A patent/SG172458A1/en unknown
- 2009-12-10 ES ES09768339T patent/ES2398023T3/es active Active
- 2009-12-10 EP EP09768339A patent/EP2373647B1/de active Active
- 2009-12-10 SI SI200930433T patent/SI2373647T1/sl unknown
- 2009-12-10 WO PCT/EP2009/008839 patent/WO2010078909A1/de active Application Filing
- 2009-12-10 MX MX2011007209A patent/MX2011007209A/es active IP Right Grant
- 2009-12-10 BR BRPI0923903A patent/BRPI0923903B8/pt active IP Right Grant
- 2009-12-10 KR KR1020117018119A patent/KR101669696B1/ko active IP Right Grant
- 2009-12-10 AU AU2009336851A patent/AU2009336851B2/en active Active
- 2009-12-10 JP JP2011544797A patent/JP5683488B2/ja active Active
- 2009-12-10 PT PT97683395T patent/PT2373647E/pt unknown
- 2009-12-10 PL PL09768339T patent/PL2373647T3/pl unknown
- 2009-12-10 CA CA2749015A patent/CA2749015C/en active Active
-
2010
- 2010-01-08 AR ARP100100034A patent/AR074997A1/es active IP Right Grant
-
2011
- 2011-06-28 IL IL213826A patent/IL213826A/en not_active IP Right Cessation
- 2011-08-05 ZA ZA2011/05781A patent/ZA201105781B/en unknown
-
2012
- 2012-11-29 HR HRP20120976AT patent/HRP20120976T1/hr unknown
- 2012-12-21 CY CY20121101250T patent/CY1113700T1/el unknown
-
2013
- 2013-01-18 SM SM201300010T patent/SMT201300010B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EA201101038A1 (ru) | 2012-01-30 |
PL2373647T3 (pl) | 2013-03-29 |
ZA201105781B (en) | 2012-04-25 |
DE102009004061A1 (de) | 2010-07-15 |
ES2398023T3 (es) | 2013-03-13 |
SI2373647T1 (sl) | 2013-01-31 |
CY1113700T1 (el) | 2016-06-22 |
IL213826A0 (en) | 2011-07-31 |
HRP20120976T1 (hr) | 2012-12-31 |
EP2373647A1 (de) | 2011-10-12 |
US8623870B2 (en) | 2014-01-07 |
BRPI0923903B8 (pt) | 2021-05-25 |
JP2012514612A (ja) | 2012-06-28 |
US20110269771A1 (en) | 2011-11-03 |
SG172458A1 (en) | 2011-08-29 |
DK2373647T3 (da) | 2012-12-10 |
AU2009336851A1 (en) | 2011-08-25 |
KR20110099799A (ko) | 2011-09-08 |
IL213826A (en) | 2016-07-31 |
KR101669696B1 (ko) | 2016-10-27 |
CN102272131A (zh) | 2011-12-07 |
EA020574B1 (ru) | 2014-12-30 |
MX2011007209A (es) | 2011-08-04 |
AU2009336851B2 (en) | 2016-03-03 |
EP2373647B1 (de) | 2012-10-31 |
BRPI0923903B1 (pt) | 2020-03-24 |
AR074997A1 (es) | 2011-03-02 |
SMT201300010B (it) | 2013-03-08 |
JP5683488B2 (ja) | 2015-03-11 |
CA2749015A1 (en) | 2010-07-15 |
PT2373647E (pt) | 2013-01-30 |
WO2010078909A1 (de) | 2010-07-15 |
CA2749015C (en) | 2017-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1013246A2 (pt) | derivados de benzofuralina | |
BR112012002828A2 (pt) | derivados de 5-fluorpirimidinona | |
BR112012015868A2 (pt) | derivados de imidazolidinadiona | |
BRPI0923497A2 (pt) | derivados de piridazinona | |
BR112012004969A2 (pt) | derivados de bis-benzimidazol | |
BR112012002662A2 (pt) | derivados de bis-benzimidazol | |
ECSP12011999A (es) | Derivados benzamida sustituidos | |
BR112012000763A2 (pt) | derivados de piridin-4-ila | |
BRPI0814616A2 (pt) | Derivados de piridazinona | |
BRPI1013844A2 (pt) | derivados de piridina-isoxazol | |
BRPI1008774A2 (pt) | espiroamida substituída | |
BRPI0812247A2 (pt) | Derivados de piridazinona | |
DK2397480T3 (da) | Diazepindionderivat | |
BRPI0915064A2 (pt) | derivados de qunoxalinadiona | |
BRPI0913832A2 (pt) | derivados de pirrolopiridinilpirimidin-2-ilamina | |
BRPI0821743A2 (pt) | derivados de piridazinona | |
BRPI1014454A2 (pt) | derivados de isoxazol-pirazol | |
BRPI0911161A2 (pt) | derivado de piridazinona | |
DK2387580T3 (da) | Deoxyactagardinderivater | |
BRPI0913234A2 (pt) | derivados de tiazolilpiperidina | |
BR112012016923A2 (pt) | Derivados de pirazol | |
BR112012002810A2 (pt) | derivados de n1-acil-5-fluoropirimidinona | |
BRPI1008007A2 (pt) | derivados de piridazinona substituídos por heteroarila | |
BRPI1011416A2 (pt) | derivados de antraquinova novos | |
BR112012002807A2 (pt) | derivados de 5-flúor-2-oxopirimidina-1(2h)-caboxilato |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/03/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/12/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |